News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Myeloma Paper of the Day, June 16th, suggested by Robert Orlowski
Jun 16, 2025, 16:01

Myeloma Paper of the Day, June 16th, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: EMMY study of patients retreated with anti-CD38 shows median PFS of 5.1 months (23.6 in patients sensitive to anti-CD38 vs. 4.6 if non-sensitive; median OS 17.3 months for all patients (14.8 mos in non-sensitive vs. NR in sensitive).”

Title: Retreatment With Anti-CD38-Based Combinations in Multiple Myeloma in Real-Life: Results From the Emmy Cohort Study

Authors: Alexis Talbot, Cyrille Hulin, Aurore Perrot, Margaret Macro, Karim Belhadj Merzoug, Mohamed Mohty, Arthur Bobin, Lionel Karlin, Salomon Manier, Laure Vincent, Abderrazak El Yamani, Wajed Abarah, Regis Kaphan, Thomas Chalopin, Daniel Ré, Adrienne de Labarthe, Olivier Fitoussi, Chanaz Lounis, Ronan Garlantezec, Olivier Decaux

Myeloma Paper of the Day, June 16th, suggested by Robert Orlowski

You can read the Full Article in Clinical Lymphoma, Myeloma and Leukemia.

More posts featuring Robert Orlowski.

Abderrazak El Yamani Adrienne de Labarthe Alexis Talbot Arthur Bobin Aurore Perrot cancer Chanaz Lounis Cyrille Hulin Daniel Ré Emmy Cohort Karim Belhadj-Merzoug Laure Vincent Lionel Karlin Margaret Macro Mohamed Mohty multiple myeloma Myeloma Myeloma Paper of the Day Olivier Decaux Olivier Fitoussi OncoDaily Oncology Regis Kaphan Robert Orlowski Ronan Garlantézec Salomon Manier Thomas Chalopin Wajed Abarah
Special Coverage
Insight
Jul 26, 2025, 21:30
Yan Leyfman: Managing Infection Risk in Myeloma - Time to Rethink IgRT?
Blog
Jul 26, 2025, 21:09
Ammira Al-Shabeeb: Travel Award Applications are Now Open for PMFG Summit 2025
Opinion
Jul 26, 2025, 20:53
Patrick Hwu: Sarcoma is Rare and Complex
Blog
Jul 26, 2025, 20:13
Ready to Take Your Cancer Research Career to the Next Level? - EACR
Blog
Jul 26, 2025, 20:00
EU’s Medicine Strategy is Focused on Supply Chains, But Overlooks the Deeper Risk
Blog
Jul 26, 2025, 19:45
Siddharth Sreemahadevan: I was Honored to Be Declared Second Runner-Up in the 8th SPEAK Lymphoma Programme
Opinion
Jul 26, 2025, 19:31
The AACR Immuno-Oncology Research Fellowships Provide $130,000 to Support Clinical Fellows
Blog
Jul 26, 2025, 19:14
Bishal Gyawali: Calling the Family of My Patients After They Have Passed Away - It’s the Least We Can Do
Science
Jul 26, 2025, 18:38
Incorporating Evidence-Based Approaches for Patients With GI Cancers - Society for Integrative Oncology
Blog
Jul 26, 2025, 17:31
Massimo Di Maio: A Great Opportunity Of Scientific And Cultural Exchange In Beijing
Blog
Jul 26, 2025, 16:51
The Role of Peer-to-Peer Fundraising - Conquer Cancer, The ASCO Foundation
Insight
Jul 26, 2025, 16:40
World Hepatitis Day - ELPA